NCT02433626 2019-02-01
COTI2-101
Critical Outcome Technologies Inc.
Phase 1 Unknown
Clinical Trials
6 trialsNCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT00082862 2012-02-13
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00178763 2011-03-03
FR-WB-TT
The University of Texas Health Science Center, Houston
Phase 2 Unknown
NCT00813696 2008-12-23
GIP-1
Istituti Tumori Giovanni Paolo II
Phase 3 Unknown
NCT00758381 2008-10-10
MAPS
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Phase 2 Unknown